Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 77 Pages
Report ld: 5354616
Request Sample
Customized Report
The global Microfluidic Immunoassay System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Microfluidic Immunoassay System market competitiveness, regional economic performance, and supply chain configurations.
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
The North America Microfluidic Immunoassay System market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Microfluidic Immunoassay System include Abbott Laboratories, Quidel Corporation, Abaxis, Nanōmix, Koninklijke Philips, Biosurfit SA, Micropoint Bioscience, Siloam Biosciences, NanoEnTek, OPKO Health, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Microfluidic Immunoassay System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Microfluidic Immunoassay System market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Microfluidic Cartridges in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Laboratory in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Microfluidic Immunoassay System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Microfluidic Immunoassay System Product Scope
1.2 Microfluidic Immunoassay System by Type
1.2.1 Global Microfluidic Immunoassay System Sales by Type (2020 & 2024 & 2031)
1.2.2 Microfluidic Analyzers
1.2.3 Microfluidic Cartridges
1.2.4 Other
1.3 Microfluidic Immunoassay System by Application
1.3.1 Global Microfluidic Immunoassay System Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Global Microfluidic Immunoassay System Market Estimates and Forecasts (2020-2031)
1.4.1 Global Microfluidic Immunoassay System Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Microfluidic Immunoassay System Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Microfluidic Immunoassay System Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Microfluidic Immunoassay System Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Microfluidic Immunoassay System Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Microfluidic Immunoassay System Sales Market Share by Region (2020-2025)
2.2.2 Global Microfluidic Immunoassay System Revenue Market Share by Region (2020-2025)
2.3 Global Microfluidic Immunoassay System Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Microfluidic Immunoassay System Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Microfluidic Immunoassay System Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Microfluidic Immunoassay System Market Size and Prospective (2020-2031)
2.4.2 Europe Microfluidic Immunoassay System Market Size and Prospective (2020-2031)
2.4.3 China Microfluidic Immunoassay System Market Size and Prospective (2020-2031)
2.4.4 Japan Microfluidic Immunoassay System Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Microfluidic Immunoassay System Historic Market Review by Type (2020-2025)
3.1.1 Global Microfluidic Immunoassay System Sales by Type (2020-2025)
3.1.2 Global Microfluidic Immunoassay System Revenue by Type (2020-2025)
3.1.3 Global Microfluidic Immunoassay System Price by Type (2020-2025)
3.2 Global Microfluidic Immunoassay System Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Microfluidic Immunoassay System Sales Forecast by Type (2026-2031)
3.2.2 Global Microfluidic Immunoassay System Revenue Forecast by Type (2026-2031)
3.2.3 Global Microfluidic Immunoassay System Price Forecast by Type (2026-2031)
3.3 Different Types Microfluidic Immunoassay System Representative Players
4 Global Market Size by Application
4.1 Global Microfluidic Immunoassay System Historic Market Review by Application (2020-2025)
4.1.1 Global Microfluidic Immunoassay System Sales by Application (2020-2025)
4.1.2 Global Microfluidic Immunoassay System Revenue by Application (2020-2025)
4.1.3 Global Microfluidic Immunoassay System Price by Application (2020-2025)
4.2 Global Microfluidic Immunoassay System Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Microfluidic Immunoassay System Sales Forecast by Application (2026-2031)
4.2.2 Global Microfluidic Immunoassay System Revenue Forecast by Application (2026-2031)
4.2.3 Global Microfluidic Immunoassay System Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Microfluidic Immunoassay System Application
5 Competition Landscape by Players
5.1 Global Microfluidic Immunoassay System Sales by Players (2020-2025)
5.2 Global Top Microfluidic Immunoassay System Players by Revenue (2020-2025)
5.3 Global Microfluidic Immunoassay System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microfluidic Immunoassay System as of 2024)
5.4 Global Microfluidic Immunoassay System Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Microfluidic Immunoassay System, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Microfluidic Immunoassay System, Product Type & Application
5.7 Global Key Manufacturers of Microfluidic Immunoassay System, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Microfluidic Immunoassay System Sales by Company
6.1.1.1 North America Microfluidic Immunoassay System Sales by Company (2020-2025)
6.1.1.2 North America Microfluidic Immunoassay System Revenue by Company (2020-2025)
6.1.2 North America Microfluidic Immunoassay System Sales Breakdown by Type (2020-2025)
6.1.3 North America Microfluidic Immunoassay System Sales Breakdown by Application (2020-2025)
6.1.4 North America Microfluidic Immunoassay System Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Microfluidic Immunoassay System Sales by Company
6.2.1.1 Europe Microfluidic Immunoassay System Sales by Company (2020-2025)
6.2.1.2 Europe Microfluidic Immunoassay System Revenue by Company (2020-2025)
6.2.2 Europe Microfluidic Immunoassay System Sales Breakdown by Type (2020-2025)
6.2.3 Europe Microfluidic Immunoassay System Sales Breakdown by Application (2020-2025)
6.2.4 Europe Microfluidic Immunoassay System Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Microfluidic Immunoassay System Sales by Company
6.3.1.1 China Microfluidic Immunoassay System Sales by Company (2020-2025)
6.3.1.2 China Microfluidic Immunoassay System Revenue by Company (2020-2025)
6.3.2 China Microfluidic Immunoassay System Sales Breakdown by Type (2020-2025)
6.3.3 China Microfluidic Immunoassay System Sales Breakdown by Application (2020-2025)
6.3.4 China Microfluidic Immunoassay System Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Microfluidic Immunoassay System Sales by Company
6.4.1.1 Japan Microfluidic Immunoassay System Sales by Company (2020-2025)
6.4.1.2 Japan Microfluidic Immunoassay System Revenue by Company (2020-2025)
6.4.2 Japan Microfluidic Immunoassay System Sales Breakdown by Type (2020-2025)
6.4.3 Japan Microfluidic Immunoassay System Sales Breakdown by Application (2020-2025)
6.4.4 Japan Microfluidic Immunoassay System Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Information
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Abbott Laboratories Microfluidic Immunoassay System Products Offered
7.1.5 Abbott Laboratories Recent Development
7.2 Quidel Corporation
7.2.1 Quidel Corporation Company Information
7.2.2 Quidel Corporation Business Overview
7.2.3 Quidel Corporation Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Quidel Corporation Microfluidic Immunoassay System Products Offered
7.2.5 Quidel Corporation Recent Development
7.3 Abaxis
7.3.1 Abaxis Company Information
7.3.2 Abaxis Business Overview
7.3.3 Abaxis Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Abaxis Microfluidic Immunoassay System Products Offered
7.3.5 Abaxis Recent Development
7.4 Nanōmix
7.4.1 Nanōmix Company Information
7.4.2 Nanōmix Business Overview
7.4.3 Nanōmix Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Nanōmix Microfluidic Immunoassay System Products Offered
7.4.5 Nanōmix Recent Development
7.5 Koninklijke Philips
7.5.1 Koninklijke Philips Company Information
7.5.2 Koninklijke Philips Business Overview
7.5.3 Koninklijke Philips Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Koninklijke Philips Microfluidic Immunoassay System Products Offered
7.5.5 Koninklijke Philips Recent Development
7.6 Biosurfit SA
7.6.1 Biosurfit SA Company Information
7.6.2 Biosurfit SA Business Overview
7.6.3 Biosurfit SA Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Biosurfit SA Microfluidic Immunoassay System Products Offered
7.6.5 Biosurfit SA Recent Development
7.7 Micropoint Bioscience
7.7.1 Micropoint Bioscience Company Information
7.7.2 Micropoint Bioscience Business Overview
7.7.3 Micropoint Bioscience Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Micropoint Bioscience Microfluidic Immunoassay System Products Offered
7.7.5 Micropoint Bioscience Recent Development
7.8 Siloam Biosciences
7.8.1 Siloam Biosciences Company Information
7.8.2 Siloam Biosciences Business Overview
7.8.3 Siloam Biosciences Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Siloam Biosciences Microfluidic Immunoassay System Products Offered
7.8.5 Siloam Biosciences Recent Development
7.9 NanoEnTek
7.9.1 NanoEnTek Company Information
7.9.2 NanoEnTek Business Overview
7.9.3 NanoEnTek Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.9.4 NanoEnTek Microfluidic Immunoassay System Products Offered
7.9.5 NanoEnTek Recent Development
7.10 OPKO Health
7.10.1 OPKO Health Company Information
7.10.2 OPKO Health Business Overview
7.10.3 OPKO Health Microfluidic Immunoassay System Sales, Revenue and Gross Margin (2020-2025)
7.10.4 OPKO Health Microfluidic Immunoassay System Products Offered
7.10.5 OPKO Health Recent Development
8 Microfluidic Immunoassay System Manufacturing Cost Analysis
8.1 Microfluidic Immunoassay System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Microfluidic Immunoassay System
8.4 Microfluidic Immunoassay System Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Microfluidic Immunoassay System Distributors List
9.3 Microfluidic Immunoassay System Customers
10 Microfluidic Immunoassay System Market Dynamics
10.1 Microfluidic Immunoassay System Industry Trends
10.2 Microfluidic Immunoassay System Market Drivers
10.3 Microfluidic Immunoassay System Market Challenges
10.4 Microfluidic Immunoassay System Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 127
USD 3950.00
(Single User License)
The global Microfluidic Immunoassay System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 111
USD 2900.00
(Single User License)
The global Microfluidic Immunoassay System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 141
USD 4900.00
(Single User License)
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 102
USD 3950.00
(Single User License)
The global market for Microfluidic Immunoassay System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 85
USD 2900.00
(Single User License)
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
Published Date: 2024-01-14
Pages: 95
USD 2900.00
(Single User License)
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 127
The global Microfluidic Immunoassay System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 111
The global Microfluidic Immunoassay System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 141
The global market for Microfluidic Immunoassay System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 102
The global market for Microfluidic Immunoassay System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 85
Microfluidic immunoassay systems are used for disease diagnostic, environmental monitoring, and food and drug screening.
Published: 2024-01-14
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now